Looking Forward to IFN 2021: Stephen D. Silberstein, MD

“Being a headache specialist, what’s exciting to me is that I’m learning about things at a high level, about other neurological disorders, that I wouldn’t normally hear about.”

Stephen D. Silberstein, MD, director of the headache center at Jefferson University Hospital, sat down with NeurologyLive to discuss the upcoming third annual International Congress on the Future of Neurology (IFN). Held September 17-18, 2021 at the InterContinental New York Barclay, IFN 2021 is anticipated to provide the latest updates and advancements in the world of neurology. 

Silberstein, who is co-chair of IFN 2021 and delivering the opening keynote lecture, noted the topics that will be discussed by migraine experts, namely intervention, prevention, and nonpharmacological interventions. Additionally, Silberstein expressed his excitement to hear about other neurological disorders that otherwise fall outside of his subspecialty in migraine. Innovations, new treatments, and preventive therapies in Alzheimer disease and Parkinson disease were areas of particular interest, as well as the use of deep brain stimulation for the treatment of movement disorders, which is also being studied for patients with headache. 

This year’s conference will be in hybrid format, allowing for attendees to attend in person or join virtually. Regardless of a healthcare provider’s focus within the neurological space, IFN 2021 offers the ability to interact with other specialists, according to Silberstein, creating an educational, multidisciplinary learning experience. 

For more coverage of IFN 2021, click here. For more information and to register for the meeting, click here.